Company profile for BlueWillow Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines and topical anti-infective products, based on its patented nanotechnology platform. The company was originally founded as NanoBio Corporation, a spin-off from the Center for Biologic Nanotechnology at the University of Michigan, and was initially focused on developing nano-scale dermatology applicati...
BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines and topical anti-infective products, based on its patented nanotechnology platform. The company was originally founded as NanoBio Corporation, a spin-off from the Center for Biologic Nanotechnology at the University of Michigan, and was initially focused on developing nano-scale dermatology applications. BlueWillow has continued to advance certain novel topical wound applications largely through partnerships under the company’s NanoBio™ division

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2311 Green Road Ann Arbor, Michigan 48105
Telephone
Telephone
734-302-4000
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/17/3152017/0/en/NANOBIOTIX-Announces-New-Results-From-a-Phase-1-Study-Evaluating-JNJ-1900-NBTXR3-in-Combination-With-Immune-Checkpoint-Inhibitors-as-a-2L-Therapy-for-Patients-With-Primary-Cutaneou.html

GLOBENEWSWIRE
17 Sep 2025

https://www.globenewswire.com/news-release/2024/10/28/2970038/0/en/BlueWillow-Biologics-to-Present-Significant-Progress-on-Its-Novel-Intranasal-Vaccine-Technology-at-World-Vaccine-Congress-Europe.html

#N/A
28 Oct 2024

https://www.businesswire.com/news/home/20220302005134/en

BUSINESSWIRE
02 Mar 2022

https://www.fiercebiotech.com/biotech/bluewillow-shares-early-look-at-data-nasal-anthrax-vaccine

FIERCEPBIOTECH
24 Aug 2021

https://pharmaceutical-business-review.com/news/medigen-bluewillow-sars-cov-2/

PHARMACEUTICAL-TECHNOLOGY
10 Nov 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty